National University of Singapore

The novel technology uses DNA-barcoded antibodies to enable single-cell RNA sequencing platforms to detect and quantify protein expression.

While the '3G' study did not establish clinical utility, the researchers said it shows genomic profiling to guide gastric cancer treatment is feasible.

Under the agreement, the researchers plan to sequence 150 AML genomes and transcriptomes to look for population-specific variants.

The Singaporean firm already offers cell-free NIPT testing through its iGene Laboratory and sells a kit to test ovarian cysts for malignancy.

This Week in Nature

In Nature this week: trove of data from the Genotype Tissue Expression consortium, and more.

Durio zibethinus

Using new genome and transcriptome sequences, researchers saw expansions and expression jumps in sulfur and fruit ripening pathways in Durio zibethinus.

The partners will work with academic and industrial partners in biomedical research with the goal of accelerating cancer detection and screening.

The university will have access to the Agilent technology for use in a study of patient responses to cardiovascular drugs.

NEW YORK (GenomeWeb News) – A new company spun out of the National University of Singapore (NUS) launched today with a technology that it said can instantly provide a diagnosis for gastric and esophageal cancers during endoscopy.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and the National University of Singapore today announced the signing of a memorandum of understanding to develop a strategic alliance to increase advance basic and applied research in Singapore.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.